Compare RUSHA & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RUSHA | LQDA |
|---|---|---|
| Founded | 1965 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail-Auto Dealers and Gas Stations | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6B | 5.5B |
| IPO Year | 1996 | 2020 |
| Metric | RUSHA | LQDA |
|---|---|---|
| Price | $78.55 | $75.63 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 11 |
| Target Price | ★ $76.75 | $41.00 |
| AVG Volume (30 Days) | 472.8K | ★ 1.7M |
| Earning Date | 04-28-2026 | 05-08-2026 |
| Dividend Yield | ★ 1.06% | N/A |
| EPS Growth | N/A | ★ 51.81 |
| EPS | ★ 1.68 | 1.26 |
| Revenue | ★ $7,434,195,000.00 | $158,320,000.00 |
| Revenue This Year | N/A | $278.87 |
| Revenue Next Year | $5.44 | $57.13 |
| P/E Ratio | ★ $46.63 | $59.79 |
| Revenue Growth | N/A | ★ 1031.18 |
| 52 Week Low | $45.67 | $21.15 |
| 52 Week High | $83.61 | $93.61 |
| Indicator | RUSHA | LQDA |
|---|---|---|
| Relative Strength Index (RSI) | 45.29 | 41.00 |
| Support Level | $70.00 | $70.28 |
| Resistance Level | $80.17 | $82.96 |
| Average True Range (ATR) | 1.98 | 4.81 |
| MACD | -0.63 | -1.92 |
| Stochastic Oscillator | 6.71 | 10.33 |
Rush Enterprises Inc is a full-service, integrated retailer of commercial vehicles and related services. The company operates in a single segment; Truck Segment includes the operation of a network of commercial vehicle dealerships under the name Rush Truck Centers. It sells commercial vehicles manufactured by Peterbilt, International, Hino, Ford, Isuzu, IC Bus, and Blue Bird and also provides one-stop service for the needs of commercial vehicle customers, including retail sales of new and used commercial vehicles, aftermarket parts sales, service and repair facilities, financing, leasing and rental, and insurance products. The company's business is concentrated in the United States and Ontario, Canada commercial vehicle markets and related aftermarkets.
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.